ZURICH – Digtial health company Oviva has raised $12 million in Series A funding to expand its operations across Europe and further develop its technology and nutritional treatment programs for people with diabetes and other chronic conditions. “With our technology, patients are empowered to take a leading role in managing their health,” said Kai Eberhardt, CEO and co-founder of Oviva, in a statement. “With the additional funding, we can refine our systems and gain deeper insights into the most successful techniques to help people change their behavior.” Oviva’s system uses virtual clinics and high frequency follow up to improve clinical outcomes, lowering the cost of care. Its app allows patients to message their dietitian directly and self-record their food intake, weight and activity.
You are here: / / Oviva raises $12M for diabetes nutrition platform